Diagnostic testing for:
Immediately after collection, mix tube thoroughly by gentle inversion, 8 - 10 times, to prevent clotting
Lavender (EDTA), 10mL
Yellow ACD (A or B)
Yellow ACD (A or B)
Molecular Medicare billing request
Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medical billing request form along with the sample.
Ambient
Polymerase chain reaction (PCR) followed by capillary electrophoresis and Southern blot (SB) analysis.
An interpretive report will be provided
Fragile X syndrome is the leading cause of inherited intellectual disability, affecting approximately 1 in 4,000 males and 1 in 8,000 females. It is found in all ethnic groups, and can occur in families with no history of intellectual disability. Women may decide to have testing to find out if they are carriers, and therefore are at risk of having a child with Fragile X syndrome. The carrier frequency in women is approximately 1 in 260. Fragile X Test is commonly used for individuals at higher risk, including those that may be symptomatic or have a family history suggestive of Fragile X syndrome.
Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medical billing request form along with the sample.